This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. , Der Wissenschaft En E.v., Technical University of Munich. Active years: 2022-2026.
Company Filing History:
2 out of 1,327 
1 out of 1 
1 out of 151 
Years Active: 2022-2026
Title: Han Remaut: Innovator in Medical Treatments
Introduction
Han Remaut is a notable inventor based in Vertrijk, Belgium. He has made significant contributions to the field of medical treatments, particularly in the prevention and treatment of infections. With a total of 2 patents, his work has the potential to impact healthcare positively.
Latest Patents
One of Han Remaut's latest patents is titled "Agents and Methods for the Prevention or Treatment of H. Pylori Infections." This invention focuses on methods for treating infections by utilizing inhibitors that affect the interaction between IIopQ and members of the carcinoembryonic antigen-related cell adhesion molecule (CEACAM) family. Additionally, it includes immunogenic compositions based on HopQ, which can be used for preventing or treating diseases associated with H. Pylori infections.
Career Highlights
Throughout his career, Han Remaut has worked with prestigious organizations such as the Max Planck Society for the Advancement of Science and the Technical University of Munich. His experience in these institutions has contributed to his expertise in medical research and innovation.
Collaborations
Han has collaborated with notable colleagues, including Tobias Kruse and Daniel Hornburg. These partnerships have likely enriched his research and development efforts in the medical field.
Conclusion
In summary, Han Remaut is a distinguished inventor whose work in medical treatments has led to valuable patents. His contributions to the prevention and treatment of infections demonstrate his commitment to advancing healthcare solutions.